MoneyWorks4Me

Lincoln Pharmaceuticals informs about press release

15 Nov 2024 Evaluate
Lincoln Pharmaceuticals has informed that it enclosed copies of newspaper intimation with respect to un-audited financial results for the quarter and half year ended on 30.09.2024.

The above information is a part of company’s filings submitted to BSE.

Lincoln Pharma Share Price

621.85 9.95 (1.63%)
25-Aug-2026 13:52 View Price Chart
Peers
Company Name CMP
Sun Pharma. Inds. 1903.95
Dr. Reddys Labs. 1181.75
Cipla 1417.65
Lupin 2173.65
Zydus Lifesciences 1110.20
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through: